Decision Making in Gynecologic Oncology
Churchill Livingstone (Publisher)
Will be published approx. on 20. October 2026
Book
Paperback/Softback
320 pages
978-0-443-12480-8 (ISBN)
Description
Designed for physicians who are managing women with gynecologic malignancies, Decision Making in Gynecologic Oncology is a practical reference to help guide daily clinical decision making. Organized by cancer type and specific disease for quick reference, each chapter presents key concepts in an algorithmic format, using easy-to-interpret decision trees that visually outline the critical steps and choices involved in patient management. Brief explanatory text accompanies each algorithm, clarifying the significance of important decision points and encouraging systematic, logical thinking throughout the diagnostic and surgical process.
Contains dozens of algorithms that follow a consistent format for quick and easy navigation, with clear explanatory notes alongside each decision tree
Provides algorithms for a wide variety of common and rare diseases, including premalignant lesions, vulvar cancer, vaginal cancer, cervical cancer, endometrial cancer, ovarian cancer, and gestational trophoblastic disease, as well as management of surgical complications, pelvic exenteration, ERAS, nutrition, palliative care, hereditary syndromes, and more
Covers common clinical diagnostic and management situations, serving as a useful teaching tool for trainees or a quick reference for physicians and surgeons wanting a brief, uncluttered format to support rapid decision making
An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
Contains dozens of algorithms that follow a consistent format for quick and easy navigation, with clear explanatory notes alongside each decision tree
Provides algorithms for a wide variety of common and rare diseases, including premalignant lesions, vulvar cancer, vaginal cancer, cervical cancer, endometrial cancer, ovarian cancer, and gestational trophoblastic disease, as well as management of surgical complications, pelvic exenteration, ERAS, nutrition, palliative care, hereditary syndromes, and more
Covers common clinical diagnostic and management situations, serving as a useful teaching tool for trainees or a quick reference for physicians and surgeons wanting a brief, uncluttered format to support rapid decision making
An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Elsevier Health Sciences
Target group
Professional and scholarly
Product notice
Paperback (trade)
Unsewn / adhesive bound
Dimensions
Height: 276 mm
Width: 216 mm
Weight
449 gr
ISBN-13
978-0-443-12480-8 (9780443124808)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Persons
Pedro T. Ramirez MD is Professor of Gynecologic Oncology at MD Anderson Cancer Center in Houston, Texas. He has authored and co-authored 264 scientific publications and has written 19 book chapters, monographs, and invited articles. He is also the Editor-in-Chief of the International Journal of Gynecological Cancer. In addition, he is the Director of the Enhanced Recovery After Surgery (ERAS) Gynecologic Oncology Program at MD Anderson Cancer Center.
Dr. Ramirez is the Principal Investigator of numerous prospective trials, including the LACC Trial. His areas of research interest include outcomes of minimally invasive surgery in gynecologic cancers and enhanced recovery after surgery implementation pathways.
Dr. Ramirez is the Principal Investigator of numerous prospective trials, including the LACC Trial. His areas of research interest include outcomes of minimally invasive surgery in gynecologic cancers and enhanced recovery after surgery implementation pathways.
Editor
Department of Obstetrics and Gynecology, Editor-in-Chief, International Journal of Gynecological Cancer, Houston Methodist Hospital, Neal Cancer Center, Houston, Texas, USA
Catholic University of the Sac, Rome, Italy